Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.

Ultragenyx Pharmaceutical has reported the failure of a pair of late-phase brittle bone disease trials, prompting the biotech to prepare to significantly reduce its spending.

Shares in Ultragenyx and Mereo BioPharma have plunged after their drug for osteogenesis imperfecta (OI) or brittle bone ...

Jay Manuel, 28, and Pamela Chavez, 30, were both born with osteogenesis imperfecta type 3 — often called brittle bone disease. The rare genetic bone disorder makes people more susceptible to breaking ...

INDIANAPOLIS –– An Indianapolis professor wants to bring more attention to osteoporosis and how people can better maintain their bone health. Rachel Surowiec is a Purdue biomedical engineering ...

May is National Osteoporosis Awareness and Prevention Month. The very common condition of osteoporosis occurs when the body doesn’t create enough bone tissue to keep up with the amount that is ...

A Claremore woman is speaking about her experience with a disease that most people have never heard of. Mihaley Schlegel, 20, has osteogenesis imperfecta, a rare disease that causes brittle bones. She ...

An Indian boy is being described as “made of glass” due to a rare condition in which his bones break at the slightest touch. Rohit, 12, suffers from osteogenesis imperfectas, more commonly known as ...

Stress is a familiar foe in 2025, with packed schedules, rising costs, and digital overload keeping tensions high. While its toll on mental health is well-known, its damage to bones often goes ...